(Q37868442)

24 August 2017

1 reference

title

Loop diuretics in heart failure (English)

1 reference

24 August 2017

0 references

1

G Michael Felker

1 reference

24 August 2017

publication date

1 March 2012

1 reference

24 August 2017

published in

Heart Failure Reviews

1 reference

24 August 2017

volume

17

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

305-311

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-011-9245-3

24 August 2017

exact match

0 references

cites work

Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Searching for evidence: Refractory questions in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Diuretic therapy and resistance in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Diuretic strategies in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Combination of loop diuretics with thiazide-type diuretics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Furosemide and the progression of left ventricular dysfunction in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Chronic ambulatory intracardiac pressures and future heart failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9245-3

Mechanism of impaired natriuretic response to furosemide during prolonged therapy

21 January 2018

1 reference

12 December 2020

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

12 December 2020

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure

1 reference

12 December 2020

Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment

1 reference

12 December 2020

Continuous infusion versus bolus injection of loop diuretics in congestive heart failure

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction

1 reference

12 December 2020

Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?

1 reference

12 December 2020

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

12 December 2020

10.1007/S10741-011-9245-3

Identifiers

DOI

1 reference

24 August 2017

1 reference